Short answer · Medically reviewed summary · Last updated: 2026-05-08
A pituitary tumour is more common than previously thought, with autopsy and imaging studies suggesting a prevalence of approximately 1 in 1,000 to 1 in 5,000 people in the general population. While many remain asymptomatic and undiagnosed, clinical incidence is estimated at 4 to 10 cases per 100,000 people per year, though these figures vary significantly based on diagnostic criteria. Is a pituitary tumour considered a rare disease? While often categorized under rare disease frameworks due to the complexity of treatment, a pituitary tumour is technically more common than many other rare conditions.
What is the prevalence of Pituitary tumour?
Prevalence of Pituitary tumour: how many people are affected worldwide, differences by sex and region, with sources.
A pituitary tumour is more common than previously thought, with autopsy and imaging studies suggesting a prevalence of approximately 1 in 1,000 to 1 in 5,000 people in the general population. While many remain asymptomatic and undiagnosed, clinical incidence is estimated at 4 to 10 cases per 100,000 people per year, though these figures vary significantly based on diagnostic criteria.
Is a pituitary tumour considered a rare disease?
While often categorized under rare disease frameworks due to the complexity of treatment, a pituitary tumour is technically more common than many other rare conditions. Because many small, non-secreting adenomas never cause symptoms, they are often discovered incidentally during brain imaging for other issues. This means the clinical prevalence of a symptomatic pituitary tumour is lower than the true biological prevalence.
How does age and gender impact a pituitary tumour diagnosis?
A pituitary tumour can affect individuals of any age, though they are most frequently diagnosed in adults between the ages of 30 and 60. Pediatric cases are significantly rarer. Regarding gender, certain types of pituitary tumour show distinct patterns:
- Prolactinomas are more frequently diagnosed in females during reproductive years.
- Non-functioning adenomas show a slightly higher prevalence in males.
- Age of onset is rarely pediatric, with the vast majority of cases occurring in mid-to-late adulthood.
Why is accurate prevalence data for a pituitary tumour challenging?
Determining exact numbers is difficult because a pituitary tumour is frequently underdiagnosed. Many individuals live their entire lives without knowing they have a small adenoma. Furthermore, at DiseaseMaps.org, we have 97 members who have joined our community to share their experiences with a pituitary tumour, providing a vital real-world perspective that clinical statistics often miss by focusing only on those in active treatment.
Are there geographic or ethnic variations?
There is no strong evidence suggesting that a pituitary tumour is more prevalent in specific ethnic or geographic groups. Most variations in reported data are attributed to differences in access to MRI technology and the frequency of incidental findings in different healthcare systems.
Next steps
- Consult an endocrinologist to discuss symptoms like vision changes or hormonal imbalances.
- Request a referral to a neurosurgeon if imaging confirms a mass.
- Join the DiseaseMaps.org community to connect with others who have been diagnosed with a pituitary tumour.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- Pituitary Foundation: Clinical prevalence statistics
- PubMed: Meta-analysis of pituitary adenoma prevalence in autopsy studies
